Tags : Johnson&Johnson

Insights+

PharmaShots’ Most Read News of 2020

“Lockdown’ declared Collins Dictionary word of the year. The year 2020, well known as COVID-19 year has been a busy year for global pharma and biotech companies involved in M&A, option & licensing agreements, and gaining approvals. Our team has compiled a list of 30 most read life sciences news on PharmaShots in 2020. 1. […]Read More

Biotech Pharma

Philogen Collaborates with Johnson&Johnson (J&J), Novartis and Celgene

Shots: Philogen collaborates with J&J to discover & develop therapies utilizing Philochem’s technology (a Swizz subsidiary of Philogen) for serious conditions Philogen signs a development and commercialization agreement with Celgene for novel immunomodulatory therapies Philogen collaborates with Novartis for the research and development of immunomodulatory candidates. In 2017 & 2016, Philogen also collaborated with Boehringer […]Read More